Making Sense of Psychedelics in the CNS
Blake A Fordyce, Bryan L. Roth
The International Journal of Neuropsychopharmacology January 30, 2024 DOI: 10.1093/ijnp/pyae007 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Perspective graphical Field mathematics Cognitive science Data science Epistemology Engineering ethics Artificial intelligence |
| Citations | 4 |
| Key findings | The paper reviews the history and current techniques for studying psychedelics pharmacologically and identifies gaps in understanding their physiological effects, therapeutic limits, and treatment improvements. |
Abstract
Abstract For centuries, ancient lineages have consumed psychedelic compounds from natural sources. In the modern era, scientists have since harnessed the power of computational tools, cellular assays, and behavioral metrics to study how these compounds instigate changes on molecular, cellular, circuit-wide, and system levels. Here, we provide a brief history of psychedelics and their use in science, medicine, and culture. We then outline current techniques for studying psychedelics from a pharmacological perspective. Finally, we address known gaps in the field and potential avenues of further research to broaden our collective understanding of physiological changes induced by psychedelics, the limits of their therapeutic capabilities, and how researchers can improve and inform treatments that are rapidly becoming accessible worldwide.
Citations in the library
Cited by 4
- 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review. ACS Pharmacology & Translational Science June 14, 2024
- History of psychedelic drug science and molecular pharmacology. International review of neurobiology 2025
- Licit use of illicit drugs for treating depression: the pill and the process. Journal of Clinical Investigation June 17, 2024
- The compulsive eating paradigm: can psychedelics help in treating obesity? Journal of Eating Disorders April 7, 2025
Cites 53
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
and 48 more in the library